DR. WILL ROWLAND VOELZKE (M.D.) – Hematology & Oncology Physician, NPI 1023205697
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
368 HEMATOLOGY/ONCOLOGY in VA
Provider Addresses for DR. WILL ROWLAND VOELZKE (M.D.)
6605 W Broad St Ste A
Richmond, VA 232301714
Phone: (804) 287-3000
Fax: (804) 673-2731
Type: Location
6130 Harbourside Centre Loop
Ste 101
Midlothian, VA 231122170
Phone: (804) 378-0394
Fax: (804) 739-7649
Type: Location
8007 Discovery Dr Ste A
Richmond, VA 232298605
Phone: (804) 287-3000
Fax: (804) 673-2731
Type: Location
Glen Forest Drive, Ladue, Saint Louis County, Missouri, 63124, United States
SUITE 200
RICHMOND, VA 232263780
Phone: (804) 673-0134
Fax: (804) 673-1796
Type: Mailing
Johnston-Willis Hospital, 1401, Johnston Willis Drive, Richmond, Chesterfield County, Virginia, 23235, United States
SUITE 100
RICHMOND, VA 232354730
Phone: (804) 330-7990
Fax: (804) 330-2701
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 120 Open Payments records for all available years, with a total value of $2,638.
Total Amount is formed as General ($2,638) + Research ($0) + Ownership ($0) = $2,638.
Last reported payment date: 2024-12-23 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($321).
Total Amount
$2,638
General + Research + Ownership
Payments
120
Total payment records
General Amount
$2,638
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-23
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $321 |
| Janssen Biotech, Inc. | $253 |
| PFIZER INC. | $252 |
| E.R. Squibb & Sons, L.L.C. | $191 |
| AstraZeneca Pharmaceuticals LP | $116 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2011-09-19
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20110919000001 | I | Hematology/Oncology | VA | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 38,760 | 65 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,601 | 16 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,820 | 29 | $0 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 4,270 | 20 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 2,862 | 11 | $0 |
Insurance plans in this area (ZIP 23230)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | VA | 96415 | Infusion of chemotherapy into a vein | 149 | 32 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| Nurse Practitioner | VA | |
| - | VA | |
| Physician Assistant | VA | |
| Nurse Practitioner | VA | |
| H E M A T O L O G Y/ O N C O L O G Y | VA | |
| Nurse Practitioner | VA | |
| Hematology/Oncology, Internal Medicine | VA | |
| Nurse Practitioner | VA | |
| Medical Oncology, Hematology/Oncology, Internal Medicine | VA | |
| H E M A T O L O G Y/ O N C O L O G Y | WI |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.